Bioabsorbable scaffolds, or naturally dissolving stents, that have been investigated include base materials that are either metals or polymers. Those that have been approved in markets around the world and thus have gained the most traction are based on polymers that are similar to those used in dissolvable stitches.
Market competition is not intense. Abbott, Kyoto Medical, REVA Medical, Biotronik, Elixir Medical, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Market Analysis and Insights: Global Bioresorbable Scaffolds Market
The global Bioresorbable Scaffolds market was valued at US$ 283.6 in 2020 and will reach US$ 801.4 million by the end of 2027, growing at a CAGR of 18.9% during 2022-2027.

Global Bioresorbable Scaffolds Scope and Market Size
The global Bioresorbable Scaffolds market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bioresorbable Scaffolds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Metal-based Bioresorbable Scaffold
Polymer-based Bioresorbable Scaffold

Segment by Application
Hospital & Clinic
Medical Center

The Bioresorbable Scaffolds market is analysed and market size information is provided by regions (countries). Segment by Application, the Bioresorbable Scaffolds market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Abbott
Kyoto Medical
REVA Medical
Biotronik
Elixir Medical